Royal London Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,163
Closed -$283K 722
2025
Q1
$283K Buy
+1,163
New +$283K ﹤0.01% 719
2024
Q3
Sell
-6,895
Closed -$1.88M 638
2024
Q2
$1.88M Hold
6,895
﹤0.01% 618
2024
Q1
$2.38M Sell
6,895
-242
-3% -$83.7K 0.01% 614
2023
Q4
$2.3M Sell
7,137
-1,046
-13% -$338K 0.01% 617
2023
Q3
$2.93M Buy
8,183
+616
+8% +$221K 0.01% 603
2023
Q2
$2.87M Hold
7,567
0.01% 596
2023
Q1
$3.62M Buy
7,567
+770
+11% +$369K 0.01% 540
2022
Q4
$2.86M Buy
6,797
+1,048
+18% +$441K 0.01% 572
2022
Q3
$2.4M Sell
5,749
-204
-3% -$85.2K 0.01% 576
2022
Q2
$2.95M Sell
5,953
-245
-4% -$121K 0.01% 559
2022
Q1
$3.49M Buy
6,198
+271
+5% +$153K 0.01% 575
2021
Q4
$4.48M Hold
5,927
0.02% 523
2021
Q3
$4.42M Hold
5,927
0.02% 522
2021
Q2
$3.82M Buy
+5,927
New +$3.82M 0.02% 568
2021
Q1
Sell
-5,619
Closed -$3.28M 665
2020
Q4
$3.28M Buy
5,619
+602
+12% +$351K 0.02% 535
2020
Q3
$2.59M Buy
+5,017
New +$2.59M 0.02% 530
2019
Q1
Sell
-11,645
Closed -$2.7M 657
2018
Q4
$2.7M Buy
11,645
+417
+4% +$96.8K 0.02% 544
2018
Q3
$3.52M Sell
11,228
-482
-4% -$151K 0.04% 414
2018
Q2
$3.38M Buy
+11,710
New +$3.38M 0.03% 471
2016
Q2
$2.72M Buy
+19,045
New +$2.72M 0.04% 401
2016
Q1
Sell
-15,430
Closed -$2.15M 523
2015
Q4
$2.15M Sell
15,430
-93
-0.6% -$13K 0.03% 464
2015
Q3
$2.09M Buy
+15,523
New +$2.09M 0.03% 468
2014
Q3
Sell
-16,400
Closed -$1.99M 557
2014
Q2
$1.99M Sell
16,400
-400
-2% -$48.5K 0.05% 414
2014
Q1
$2.07M Buy
+16,800
New +$2.07M 0.05% 403